Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04405765 · ClinicalTrials.gov registry record · Phase 4
Cryopreserved vs. Lyopreserved Stravix as an Adjunct to NPWT in the Treatment of Complex Wounds
A Phase 4 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 46
- Enrollment target
NCT04405765 is a Phase 4 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 46 participants.
The verdict
NCT04405765, a Phase 4 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 46 participants
- Enrollment target
Study Summary
This study is a prospective, 2-arm parallel assignment, randomized clinical trial to compare lyopreserved vs cryopreserved Stravix as an adjunct therapy to NPWT.
Interventions
- DEVICE NPWT and lyopreserved Stravix
- DEVICE NPWT and cryopreserved Stravix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2021-06-22 |
| Est. Completion | 2022-07-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04405765
The ClinicalTrials.gov registry entry for NCT04405765 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which NPWT and lyopreserved Stravix is the first listed.
NCT04405765 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04405765 about?
NCT04405765 is a clinical study titled "Cryopreserved vs. Lyopreserved Stravix as an Adjunct to NPWT in the Treatment of Complex Wounds". This study is a prospective, 2-arm parallel assignment, randomized clinical trial to compare lyopreserved vs cryopreserved Stravix as an adjunct therapy to NPWT.
What is the current status of trial NCT04405765?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 46 participants. The study started on 2021-06-22. Estimated completion is 2022-07-07.
What interventions are being tested in trial NCT04405765?
The interventions under investigation include: NPWT and lyopreserved Stravix (DEVICE), NPWT and cryopreserved Stravix (DEVICE).
Who is sponsoring clinical trial NCT04405765?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.